Literature DB >> 11287779

Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: involvement of protein kinase C.

B Haslinger1, S Mandl-Weber, A Sellmayer, S R Lederer, T Sitter.   

Abstract

Human peritoneal mesothelial cells (HMC) contribute to the activation and control of inflammatory processes in the peritoneum by their potential to produce various inflammatory mediators. The present study was designed to assess the effect of glucose, the osmotic active compound in most commercially available peritoneal dialysis fluids, on the synthesis of the C-C chemokine monocyte chemoattractant protein-1 (MCP-1) in cultured HMC. The MCP-1 concentration in the cell supernatants was determined by enzyme-linked immunosorbent assay and the MCP-1 mRNA expression was examined using Northern blot analysis. Incubation of HMC with glucose (30-120 mM) resulted in a time- and concentration-dependent increase in MCP-1 protein secretion and mRNA expression. After 24 h the MCP-1 synthesis was increased from 2.8 +/- 0.46 to 4.2 +/- 0.32 ng/10(5) cells (n = 5, p < 0.05) in HMC treated with 60 mM glucose. In contrast, osmotic control media containing either the metabolically inert monosaccharide mannitol or NaCl did not influence MCP-1 production. The stimulating effect of high glucose on MCP-1 expression in HMC was mimicked by activation of protein kinase C (PKC) with the phorbol ester PMA (20 nM). Coincubation of the cells with glucose and the specific PKC inhibitor Ro 31-8220 completely blunted glucose-mediated MCP-1 expression. In summary, our results indicate that glucose induces MCP-1 synthesis by a PKC-dependent pathway. Since osmotic control media did not increase MCP-1 release, it is suggested that the effect of glucose is mainly related to metabolism and not to hyperosmolarity. These data may in part explain elevated steady-state levels of MCP-1 found in the dialysis effluent of continuous ambulatory peritoneal dialysis patients. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287779     DOI: 10.1159/000045941

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  6 in total

1.  Synthetic double-stranded RNA stimulates the expression of interferon-inducible protein 10 in human mesothelial cells.

Authors:  Monika Merkle; Matthias Sauter; Andrea Ribeiro; Thomas Mussack; Roland Ladurner; Thomas Sitter; Markus Wörnle
Journal:  Clin Vaccine Immunol       Date:  2010-11-24

2.  HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium.

Authors:  Min-A Yu; Kyung-Sook Shin; Jung Hye Kim; Yong-Il Kim; Soon Sup Chung; Sun-Hee Park; Yong-Lim Kim; Duk-Hee Kang
Journal:  J Am Soc Nephrol       Date:  2009-02-04       Impact factor: 10.121

3.  Novel role of toll-like receptor 3, RIG-I and MDA5 in poly (I:C) RNA-induced mesothelial inflammation.

Authors:  Markus Wörnle; Matthias Sauter; Kathrin Kastenmüller; Andrea Ribeiro; Maximilian Roeder; Holger Schmid; Florian Krötz; Thomas Mussack; Roland Ladurner; Thomas Sitter
Journal:  Mol Cell Biochem       Date:  2008-11-13       Impact factor: 3.396

4.  Recombinant GPI-anchored TIMP-1 stimulates growth and migration of peritoneal mesothelial cells.

Authors:  Roghieh Djafarzadeh; Matthias Sauter; Susan Notohamiprodjo; Elfriede Noessner; Pankaj Goyal; Wolfgang Siess; Markus Wörnle; Andrea Ribeiro; Susanne Himmelein; Thomas Sitter; Peter J Nelson
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

5.  Effect of 8-hydroxyquinoline and derivatives on human neuroblastoma SH-SY5Y cells under high glucose.

Authors:  Wilasinee Suwanjang; Supaluk Prachayasittikul; Virapong Prachayasittikul
Journal:  PeerJ       Date:  2016-08-31       Impact factor: 2.984

Review 6.  Roles of the TGF-β⁻VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis.

Authors:  Hiroshi Kinashi; Yasuhiko Ito; Ting Sun; Takayuki Katsuno; Yoshifumi Takei
Journal:  Int J Mol Sci       Date:  2018-08-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.